Example: Heart Attack
Clinical Trials Sponsored by Farah Ahmed Barakat
Total 1 results
-
NCT04221243Unknown
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Assiut University
- Pfizer
- Cairo University
- Max Planck Institute for Psycholinguistics
- René Klinkby Støving
- Duzce University
- Mayo Clinic
- M and J Western Regional Institute of Ophthalmology,Ahmedabad.
- Institute for Systems Biology
- GlaxoSmithKline
- Novartis Pharmaceuticals
- Dermavant Sciences, Inc.
- 3E Therapeutics Corporation
- CHDI Foundation, Inc.
- AstraZeneca
- Royal Sussex County Hospital
- M.D. Anderson Cancer Center
- Assistance Publique - Hôpitaux de Paris
- National Cancer Institute (NCI)
- Fresh Tracks Therapeutics, Inc.
- View Full List
Medical Conditions
- Transient Ischemic Attacks
- Hyperglycemia, Diabetes, and Obesity
- Pain
- Asthma
- Coronary Artery Disease
- Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
- Depression
- Prostate Cancer
- Epilepsy Generalized Idiopathic Not Intractable
- Norms, Social
- Stroke
- Breast Cancer
- Hypertension
- Increased Iron Storage / Disturbed Distribution
- Hereditary Transthyretin Amyloidosis With Polyneuropthy
- MicroRNA Expression Profile in Human Vitreous
- Obesity
- HIV Infections
- MULTIPLE MYELOMA
- Malignant Pleural Neoplasm
- View Full List
Drug Interventions
- LAE001
- POT-4
- naropeine or chirocaine (Arthroscopic rotator cuff repair under LRA)
- Bevacizumab
- NT-020
- carboplatin
- Cu-64 SARTATE and Cu-67 SARTATE
- EUS enhanced with contrast to evaluate pancreas
- Letrozole Plus Low-Dose Metronomic Capecitabine
- Cyclophosphamide
- Prednisone
- Cisplatin
- Paclitaxel
- Radiolabelled 14C-canagliflozin (14C-JNJ-28431754)
- Dexamethasone
- Cyclic OC (clormadinone acetate plus ethinil-estradiol)
- Capecitabine
- Docetaxel
- Gemcitabine
- Fluticasone propionate/salmeterol 100/50 µg
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Cameroon
- Contract Research Organizations in China
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Croatia
- Contract Research Organizations in Germany
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Malawi
- Contract Research Organizations in Norway
- Contract Research Organizations in Portugal
- Contract Research Organizations in Qatar
- Contract Research Organizations in Zambia
- CRO list by country